Organon & Co.
OGN· NYSE
OGNOrganon & Co.
Filed Nov 4, 2022 · 10-Q · 35 days after period end · 0001821825-22-000012
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $1.54B | $1.60B | $1.61B |
| Net Income | $227.00M | $323.00M | $547.00M |
| EPS Diluted | $0.89 | $1.27 | $2.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 4, 2022 · 35 d after period end
